Hubert Marotte

5.2k total citations
143 papers, 3.2k citations indexed

About

Hubert Marotte is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Hubert Marotte has authored 143 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Rheumatology, 34 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Hubert Marotte's work include Rheumatoid Arthritis Research and Therapies (67 papers), Systemic Lupus Erythematosus Research (21 papers) and Spondyloarthritis Studies and Treatments (18 papers). Hubert Marotte is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (67 papers), Systemic Lupus Erythematosus Research (21 papers) and Spondyloarthritis Studies and Treatments (18 papers). Hubert Marotte collaborates with scholars based in France, United States and Switzerland. Hubert Marotte's co-authors include Pierre Miossec, Stéphane Paul, Xavier Roblin, Émilie Del Tedesco, Laurent Peyrin‐Biroulet, Jean–Marc Phelip, Philippe Gaudin, Alisa E. Koch, A Moreau and Christian Genin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Gastroenterology.

In The Last Decade

Hubert Marotte

134 papers receiving 3.1k citations

Peers

Countries citing papers authored by Hubert Marotte

Since Specialization

Citations

This map shows the geographic impact of Hubert Marotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Marotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Marotte more than expected).

Fields of papers citing papers by Hubert Marotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Marotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Marotte. The network helps show where Hubert Marotte may publish in the future.

Co-authorship network of co-authors of Hubert Marotte

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Marotte. A scholar is included among the top collaborators of Hubert Marotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Marotte. Hubert Marotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐term evaluation of rheumatoid arthritis activity with erythrocyte methotrexate‐polyglutamate 3 2025 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), Sophie Hodin, (unknown), (unknown), (unknown), (unknown), Thierry Thomas, Xavier Delavenne, Hubert Marotte	2
2	Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT) 2025 ·Advances in Therapy ·Hubert Marotte, Alain Cantagrel, Fabienne Coury, Thierry Schaeverbeke, (unknown), (unknown), Y. Brault, Bruno Fautrel	0
3	Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary 2024 ·Rheumatology and Therapy ·Peter C. Taylor, Alejandro Balsa, Anne‐Barbara Mongey, Mária Filková, (unknown), (unknown), L.A.W. Verhagen, Torsten Witte, Daniela Opriș-Belinski, Hubert Marotte, Jérôme Avouac	1
4	Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol 2024 ·BMJ Open ·(unknown), Christian Marcelli, Théodora Bejan‐Angoulvant, Axel Finckh, (unknown), (unknown), (unknown), Émilie Presles, Hubert Marotte	1
5	Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study 2024 ·BioDrugs ·Guillaume Bouguen, Laure Gossec, (unknown), (unknown), Guillaume Bonnaud, Xavier Roblin, (unknown), Stéphane Nancey, (unknown), Jérôme Filippi, Lucine Vuitton, Stéphane Nahon, Azeddine Dellal, (unknown), (unknown), (unknown), (unknown), Hubert Marotte	2
6	Teleconsultation in rheumatology: A literature review and opinion paper 2023 ·Seminars in Arthritis and Rheumatism ·Jérôme Avouac, Hubert Marotte, Alejandro Balsa, (unknown), (unknown), L.A.W. Verhagen, Mária Filková, Ruediger B. Müeller, Anne‐Barbara Mongey, Peter C. Taylor	5
7	Proteomics analyses of human plasma reveal triosephosphate isomerase as a potential blood marker of methotrexate resistance in rheumatoid arthritis 2023 ·Lara D. Veeken ·(unknown), (unknown), Sophie Hodin, (unknown), (unknown), (unknown), (unknown), Thierry Thomas, Xavier Delavenne, Hubert Marotte	2
8	Protective Effect on Bone of Nacre Supplementation in Ovariectomized Rats 2022 ·JBMR Plus ·(unknown), Norbert Laroche, Arnaud Vanden‐Bossche, Marie‐Thérèse Linossier, Mireille Thomas, Sylvie Peyroche, (unknown), (unknown), Thierry Thomas, Hubert Marotte, Laurence Vico, Marie-Hélène Lafage–Proust, Marthe Rousseau	6
9	Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial 2022 ·Clinical and Experimental Rheumatology ·(unknown), Hubert Marotte, (unknown), Florence Tubach, David Hajage, Bruno Fautrel	1
10	YAP Transcriptional Activity Dictates Cell Response to TNF In Vitro 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Marie‐Thérèse Linossier, (unknown), Alain Guignandon, Laurence Vico, Hubert Marotte	15
11	An Update on the Adalimumab Biosimilar Landscape Following Approval of the First High-Concentration Biosimilar 2021 ·Immunotherapy ·Enrico Fusaro, Patrick Durez, Johannes Wohlrab, (unknown), Sang-Wook Yoon, Hubert Marotte	4
12	Reliability and Change in Erosion Measurements by High-resolution Peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis Patients 2020 ·The Journal of Rheumatology ·Stephanie Finzel, Sarah L. Manske, Cheryl Barnabé, Andrew J. Burghardt, Hubert Marotte, A. Scharmga, Ellen‐Margrethe Hauge, Roland Chapurlat, Klaus Engelke, Xiaojuan Li, (unknown), Philip G. Conaghan, Kathryn S. Stok	6
13	Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis 2020 ·Lara D. Veeken ·A. Villani, Stéphanie Boutroy, (unknown), Marie-Christine Carlier, (unknown), Hubert Marotte, Bertrand Richert, Roland Chapurlat, D. Jullien, Cyrille B. Confavreux	8
14	Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production 2019 ·Journal of Clinical Medicine ·(unknown), Céline Rodriguez, Margaux Hubert, (unknown), Christelle Machon, Jérôme Guitton, (unknown), (unknown), Hubert Marotte, Christophe Caux, Fabienne Coury, Christine Ménétrier‐Caux	5
15	How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy 2019 ·Journal of Clinical Medicine ·Peter C. Taylor, Alejandro Balsa, Anne‐Barbara Mongey, Jérôme Avouac, Hubert Marotte, (unknown)	61
16	Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial 2017 ·Alimentary Pharmacology & Therapeutics ·Xavier Roblin, Gilles Boschetti, Nicolas Williet, Stéphane Nancey, Hubert Marotte, Anne‐Emmanuelle Berger, Jean–Marc Phelip, Laurent Peyrin‐Biroulet, Jean‐Frédéric Colombel, Émilie Del Tedesco, Stéphane Paul, Bernard Flourié	89
17	Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease 2015 ·Journal of Crohn s and Colitis ·Xavier Roblin, Hubert Marotte, (unknown), Émilie Del Tedesco, Jean–Marc Phelip, Laurent Peyrin‐Biroulet, Stéphane Paul	88
18	Neutrophil dermatosis of the dorsal hands with multiple myeloma 2015 ·Joint Bone Spine ·(unknown), (unknown), Thierry Thomas, B. Labeille, Hubert Marotte	2
19	Correction 2009 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Hubert Marotte, Anne‐Christine Bay‐Jensen, Pierre Miossec, Patrick Garnero, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
20	Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis 2009 ·Lara D. Veeken ·Hubert Marotte, Jeffrey H. Ruth, Phillip L. Campbell, A E Koch, Salahuddin Ahmed	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact